XTNT vs OSPN

For growth investors, Xtant Medical Holdings, Inc.

(XTNT) is the stronger pick with 28. 4% revenue growth year-over-year, versus 0. 0% for OneSpan Inc. (OSPN). OneSpan Inc. (OSPN) offers the better valuation at 6. 2x trailing P/E (9. 6x forward), making it the more compelling value choice. Analysts rate OneSpan Inc. (OSPN) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, OneSpan Inc.

(OSPN) delivered a total return of -51. 4%, compared to -66. 1% for Xtant Medical Holdings, Inc. (XTNT). Over 10 years, the gap is even starker: OSPN returned -24. 1% versus XTNT's -97. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Xtant Medical Holdings, Inc.

(XTNT) is the lower-risk stock at 0. 69β versus OneSpan Inc. 's 1. 23β — meaning OSPN is approximately 79% more volatile than XTNT relative to the S&P 500. On balance sheet safety, OneSpan Inc. (OSPN) carries a lower debt/equity ratio of 2% versus 82% for Xtant Medical Holdings, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Xtant Medical Holdings, Inc.

(XTNT) is pulling ahead at 28. 4% versus 0. 0% for OneSpan Inc. (OSPN). Over a 3-year CAGR, XTNT leads at 28. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

OneSpan Inc.

(OSPN) is the more profitable company, earning 30. 0% net margin versus -14. 0% for Xtant Medical Holdings, Inc. — meaning it keeps 30. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: OSPN leads at 20. 6% versus -10. 3% for XTNT. At the gross margin level — before operating expenses — OSPN leads at 70. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

In this comparison, OSPN (4.

1% yield) pays a dividend. XTNT does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, OneSpan Inc.

(OSPN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 23), 4. 1% yield). Both have compounded well over 10 years (OSPN: -24. 1%, XTNT: -97. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (XTNT (Healthcare) and OSPN (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: XTNT is a small-cap high-growth stock; OSPN is a small-cap deep-value stock. OSPN pays a dividend while XTNT does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.